Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Bracco

Cardiovascular

Cardiovascular Today—May 28, 2026

This week’s Cardiovascular update highlights regulatory clearances, long-term…

Cardiovascular

Cardiovascular Today—May 21, 2026

This week’s Cardiovascular update highlights regulatory approvals, late-stage…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: AlzeCure Pharma Collaboration and Out-Licensing Agreement with Eli Lilly
Obesity Today—June 9, 2026
Endocrinology Today—June 9, 2026
Pfizer’s HYMPAVZI FDA label expansion | Lucid Diligence Brief
Oncology Today—June 8, 2026

Tags

AIRNA AMT-130 Apellis Pharmaceuticals Apple Watch Hypertension Applied Therapeutics Atera ATM-negative mCRC BILDYOS care coordination CER-1236 CLEVER CRO market DESTINY-Breast09 deupirfenidone Developmental And Epileptic Encephalopathies Diabetes Reversal Group Duke Health epitranscriptomics ETX101 FXa DOAC Genprex GRADE Heart failure with preserved ejection fraction HES Ibrutinib Iterative Health menin inhibitor Miltenyi Biomedicine MIT Mobile Shuttle Multimodal AI NHS fetal anomaly AI OGT Opioid Research OSENVELT Pediatric B-Cell Acute Lymphoblastic Leukemia Phenomix Sciences polymyalgia rheumatica Qdenga ROC-101 Servier Sirtex Medical Skye Biosciences TGF beta THIO

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: AlzeCure Pharma Collaboration and Out-Licensing Agreement with Eli Lilly
Obesity Today—June 9, 2026
Endocrinology Today—June 9, 2026
Pfizer’s HYMPAVZI FDA label expansion | Lucid Diligence Brief
Oncology Today—June 8, 2026

TAGS

AIRNA AMT-130 Apellis Pharmaceuticals Apple Watch Hypertension Applied Therapeutics Atera ATM-negative mCRC BILDYOS care coordination CER-1236 CLEVER CRO market DESTINY-Breast09 deupirfenidone Developmental And Epileptic Encephalopathies Diabetes Reversal Group Duke Health epitranscriptomics ETX101 FXa DOAC Genprex GRADE Heart failure with preserved ejection fraction HES Ibrutinib Iterative Health menin inhibitor Miltenyi Biomedicine MIT Mobile Shuttle Multimodal AI NHS fetal anomaly AI OGT Opioid Research OSENVELT Pediatric B-Cell Acute Lymphoblastic Leukemia Phenomix Sciences polymyalgia rheumatica Qdenga ROC-101 Servier Sirtex Medical Skye Biosciences TGF beta THIO

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy